Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib in Metastatic Bone Sarcomas
NCT02389244Phase 2Completed
- Sponsor
- Unicancer
- Start
- Sep 2014
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of regorafenib in bone sarcoma, sponsored by Unicancer. Started Sep 2014; status: completed.
02
Drugs
regorafenib
03
Conditions
bone sarcoma
Beyond the preview
Go deeper on NCT02389244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02389244.